CN104428311B - 肽的盐酸化物盐以及其与其他肽组合用于免疫疗法的用途 - Google Patents

肽的盐酸化物盐以及其与其他肽组合用于免疫疗法的用途 Download PDF

Info

Publication number
CN104428311B
CN104428311B CN201380036507.6A CN201380036507A CN104428311B CN 104428311 B CN104428311 B CN 104428311B CN 201380036507 A CN201380036507 A CN 201380036507A CN 104428311 B CN104428311 B CN 104428311B
Authority
CN
China
Prior art keywords
peptide
seq
peptides
sequence
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380036507.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN104428311A (zh
Inventor
保罗·莱德勒
伊姆雷·法卡什
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Niox Healthcare Ltd
Original Assignee
Circassia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Circassia Ltd filed Critical Circassia Ltd
Publication of CN104428311A publication Critical patent/CN104428311A/zh
Application granted granted Critical
Publication of CN104428311B publication Critical patent/CN104428311B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CN201380036507.6A 2012-05-11 2013-05-09 肽的盐酸化物盐以及其与其他肽组合用于免疫疗法的用途 Expired - Fee Related CN104428311B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1208293.9 2012-05-11
GB201208293A GB201208293D0 (en) 2012-05-11 2012-05-11 Hydrochlorice salt of peptide
PCT/GB2013/051201 WO2013167897A1 (en) 2012-05-11 2013-05-09 Hydrochloride salt of peptide and its use in combination with other peptides for immunotherapy

Publications (2)

Publication Number Publication Date
CN104428311A CN104428311A (zh) 2015-03-18
CN104428311B true CN104428311B (zh) 2019-11-01

Family

ID=46396890

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380036507.6A Expired - Fee Related CN104428311B (zh) 2012-05-11 2013-05-09 肽的盐酸化物盐以及其与其他肽组合用于免疫疗法的用途

Country Status (17)

Country Link
US (1) US9657061B2 (enExample)
EP (1) EP2847209B8 (enExample)
JP (1) JP5982562B2 (enExample)
KR (1) KR20150014955A (enExample)
CN (1) CN104428311B (enExample)
AU (1) AU2013257784A1 (enExample)
BR (1) BR112014028130A2 (enExample)
CA (1) CA2873120A1 (enExample)
EA (1) EA201492068A1 (enExample)
GB (2) GB201208293D0 (enExample)
HK (1) HK1201850A1 (enExample)
IL (1) IL235388A (enExample)
IN (1) IN2014DN09367A (enExample)
MX (1) MX2014013394A (enExample)
SG (1) SG11201407446TA (enExample)
WO (1) WO2013167897A1 (enExample)
ZA (1) ZA201408290B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
GB201501017D0 (en) 2014-12-23 2015-03-04 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
HRP20211754T1 (hr) 2014-12-23 2022-03-04 Immatics Biotechnologies Gmbh Novi peptidi i kombinacije peptida za upotrebu u imunoterapiji protiv hepatocelularnog karcinoma (hcc) i drugih rakova
PT3388075T (pt) 2015-03-27 2023-08-18 Immatics Biotechnologies Gmbh Novos péptidos e combinações de péptidos para uso em imunoterapia contra vários tumores
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
WO2021038431A1 (en) * 2019-08-26 2021-03-04 Auro Peptides Ltd An improved process for the preparation of etelcalcetide hydrochloride
TWI792442B (zh) * 2021-07-23 2023-02-11 建誼生技股份有限公司 依特卡肽鹽酸鹽之製造方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101808660A (zh) * 2007-06-01 2010-08-18 切尔卡西亚有限公司 抗猫变态反应的疫苗肽组合
CN102227214A (zh) * 2008-11-28 2011-10-26 切尔卡西亚有限公司 二聚体形成减少的组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4874522B2 (ja) * 2001-12-05 2012-02-15 サーカッシア リミテッド 免疫療法および系
DK1984009T3 (da) 2006-01-18 2013-01-28 Qps Llc Farmaceutiske sammensætninger med forbedret stabilitet
ES2402956T3 (es) * 2007-08-15 2013-05-10 Circassia Limited Péptido con formación de dímeros reducida
GB2455108A (en) * 2007-11-28 2009-06-03 Circassia Ltd T-Cell dependent method for detecting non-allergic or intrinsic disorders
AU2011234264B2 (en) * 2010-03-31 2016-02-04 Stabilitech Ltd Excipients for stabilising viral particles, polypeptides or biological material

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101808660A (zh) * 2007-06-01 2010-08-18 切尔卡西亚有限公司 抗猫变态反应的疫苗肽组合
CN102227214A (zh) * 2008-11-28 2011-10-26 切尔卡西亚有限公司 二聚体形成减少的组合物

Also Published As

Publication number Publication date
HK1201850A1 (en) 2015-09-11
KR20150014955A (ko) 2015-02-09
MX2014013394A (es) 2015-02-04
CA2873120A1 (en) 2013-11-14
JP2015517484A (ja) 2015-06-22
GB2517354A (en) 2015-02-18
SG11201407446TA (en) 2015-03-30
IN2014DN09367A (enExample) 2015-07-17
US20150110820A1 (en) 2015-04-23
JP5982562B2 (ja) 2016-08-31
IL235388A (en) 2016-06-30
GB201208293D0 (en) 2012-06-20
EP2847209B1 (en) 2020-08-05
WO2013167897A1 (en) 2013-11-14
EP2847209A1 (en) 2015-03-18
US9657061B2 (en) 2017-05-23
CN104428311A (zh) 2015-03-18
AU2013257784A1 (en) 2014-11-20
ZA201408290B (en) 2016-01-27
EA201492068A1 (ru) 2015-03-31
BR112014028130A2 (pt) 2017-08-15
EP2847209B8 (en) 2020-10-07
GB201421491D0 (en) 2015-01-14

Similar Documents

Publication Publication Date Title
CN104428311B (zh) 肽的盐酸化物盐以及其与其他肽组合用于免疫疗法的用途
FI92326C (fi) LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
AU2012326026B2 (en) Peptidomimetic macrocyles
CN101511823B (zh) 多功能生物活性化合物
RU2180668C2 (ru) Гептапептидные аналоги окситоцина
US20020187938A1 (en) Ghrelin antagonists
CA3045483A1 (en) Conjugates comprising an glp-1/glucagon dual agonist, a linker and hyaluronic acid
CN103987725A (zh) 具有改善的药代动力学性质的坎普他汀类似物
WO2017023933A2 (en) Peptidomimetic macrocycles
Rivier et al. Gonadotropin-releasing hormone antagonists: novel members of the azaline B family
EP0647656B1 (en) Motilin-like polypeptides that inhibit gastrointestinal motor activity
EP4011905A2 (en) Compstatin analogs with increased solubility and improved pharmacokinetic properties
JP2002528388A (ja) 環改変された環状ペプチドアナログ
US20210060121A1 (en) Novel antibiotics and methods of using them
JPH10501003A (ja) 免疫調節作用を有する新規ペプチド
KR100876538B1 (ko) Ｌｈｒｈ 길항제의 염의 제조방법
JPH0592996A (ja) 心房性ナトリウム利尿因子活性をもつペプチド
JP4401170B2 (ja) 新規ペプチドであるヒト成長ホルモン放出ホルモンの類似体
KR0171614B1 (ko) 혈관활성 바소토신 유도체
AU2002210439B2 (en) Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts
WO2019229225A1 (en) Conjugates comprising an glp-1/glucagon/gip triple receptor agonist, a linker and hyaluronic acid
AU718192B2 (en) Peptide derivatives
EP0755942A1 (en) Peptide derivative
EP1337551B1 (en) Substance p analogs for the treatment of cancer
TW202026305A (zh) 芋螺毒素(conotoxin)肽類似物及用於疼痛及發炎病症之治療的用途

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20191101

CF01 Termination of patent right due to non-payment of annual fee